Stryker Corporation (USD) Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Corporation (USD) Active

2825 Airview Boulevard, Portage, MI, US, 49002

Stock Price USD

Price Change

Last Dividend USD

B+

Latest Rating

SYK's stock peer is ABT (Abbott Laboratories)

SYK's stock peer is BSX (Boston Scientific Corporation)

SYK's stock peer is EW (Edwards Lifesciences Corporation)

SYK's stock peer is SNN (Smith & Nephew plc)

SYK's stock peer is ZBH (Zimmer Biomet Holdings, Inc.)

Healthcare Medical - Devices

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

80%

Dcf Rating

80%

Return On Equity

100%

Return On Assets

40%

Debt To Equity

20%

Price To Earnings

40%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2025-06-30	2025-07-31	0.84	0.87 %	Quarterly
2025-03-31	2025-04-30	0.84	0.88 %	Quarterly
2024-12-31	2025-01-31	0.84	0.90 %	Quarterly
2024-09-30	2024-10-31	0.80	0.89 %	Quarterly
2024-06-28	2024-07-31	0.80	0.93 %	Quarterly
2024-03-29	2024-04-30	0.80	0.86 %	Quarterly
2023-12-29	2024-01-31	0.80	1.02 %	Quarterly
2023-09-29	2023-10-31	0.75	1.10 %	Quarterly
2023-06-30	2023-07-31	0.75	0.98 %	Quarterly
2023-03-31	2023-04-28	0.75	1.03 %	Quarterly
2022-12-30	2023-01-31	0.75	1.15 %	Quarterly
2022-09-30	2022-10-31	0.69	1.35 %	Quarterly
2022-06-30	2022-07-29	0.69	1.36 %	Quarterly
2022-03-31	2022-04-29	0.69	0.98 %	Quarterly
2021-12-31	2022-01-31	0.69	0.95 %	Quarterly
2021-09-30	2021-10-29	0.63	0.94 %	Quarterly
2021-06-30	2021-07-30	0.63	0.95 %	Quarterly
2021-03-31	2021-04-30	0.63	0.99 %	Quarterly
2020-12-31	2021-01-29	0.63	0.97 %	Quarterly
2020-09-30	2020-10-30	0.57	1.12 %	Quarterly
2020-06-30	2020-07-31	0.57	1.26 %	Quarterly
2020-03-31	2020-04-30	0.57	1.34 %	Quarterly
2019-12-31	2020-01-31	0.57	1.02 %	Quarterly
2019-09-30	2019-10-31	0.52	0.97 %	Quarterly
2019-06-28	2019-07-31	0.52	1.00 %	Quarterly
2019-03-29	2019-04-30	0.52	1.01 %	Quarterly
2018-12-31	2019-01-31	0.52	1.25 %	Quarterly
2018-09-28	2018-10-31	0.47	1.07 %	Quarterly
2018-06-29	2018-07-31	0.47	1.09 %	Quarterly
2018-03-29	2018-04-30	0.47	1.13 %	Quarterly
2017-12-29	2018-01-31	0.47	1.12 %	Quarterly
2017-09-29	2017-10-31	0.42	1.21 %	Quarterly
2017-06-30	2017-07-31	0.42	1.18 %	Quarterly
2017-03-31	2017-04-28	0.42	1.22 %	Quarterly
2016-12-30	2017-01-31	0.42	1.31 %	Quarterly
2016-09-30	2016-10-31	0.38	1.30 %	Quarterly
2016-06-30	2016-07-29	0.38	1.28 %	Quarterly
2016-03-31	2016-04-29	0.38	1.36 %	Quarterly
2015-12-31	2016-01-29	0.38	1.49 %	Quarterly
2015-09-30	2015-10-30	0.34	1.49 %	Quarterly
2015-06-30	2015-07-31	0.34	1.38 %	Quarterly
2015-03-31	2015-04-30	0.34	1.40 %	Quarterly
2014-12-31	2015-01-30	0.34	1.32 %	Quarterly
2014-09-30	2014-10-31	0.30	1.50 %	Quarterly
2014-06-30	2014-07-31	0.30	1.39 %	Quarterly
2014-03-31	2014-04-30	0.30	1.43 %	Quarterly
2013-12-31	2014-01-31	0.30	1.47 %	Quarterly
2013-09-30	2013-10-31	0.27	1.55 %	Quarterly
2013-06-28	2013-07-31	0.27	1.56 %	Quarterly
2013-03-28	2013-04-30	0.27	1.47 %	Quarterly
2012-12-31	2013-01-31	0.27	1.64 %	Quarterly
2012-09-28	2012-10-31	0.21	1.53 %	Quarterly
2012-06-29	2012-07-31	0.21	1.50 %	Quarterly
2012-03-30	2012-04-30	0.21	1.43 %	Quarterly
2011-12-29	2012-01-31	0.21	1.51 %	Quarterly
2011-09-30	2011-10-31	0.18	1.48 %	Quarterly
2011-06-30	2011-07-29	0.18	1.18 %	Quarterly
2011-03-31	2011-04-29	0.18	1.08 %	Quarterly
2010-12-31	2011-01-31	0.18	1.16 %	Quarterly
2010-09-30	2010-10-29	0.15	1.20 %	Quarterly
2010-06-30	2010-07-30	0.15	0.88 %	Quarterly
2010-03-30	2010-04-30	0.15	0.53 %	Quarterly
2009-12-30	2010-01-29	0.15	0.49 %	Monthly
2009-11-18	2009-12-16	0.10	0.20 %	Annual
2008-12-31	2009-01-30	0.40	1.02 %	Annual
2007-12-31	2008-01-31	0.33	0.44 %	Annual
2006-12-29	2007-01-31	0.22	0.40 %	Annual
2005-12-30	2006-01-31	0.11	0.24 %	Annual
2004-12-31	2005-01-31	0.09	0.19 %	Annual
2003-12-31	2004-01-30	0.14	0.17 %	Annual
2002-12-31	2003-01-31	0.12	0.18 %	Annual
2001-12-31	2002-01-31	0.10	0.17 %	Annual
2000-12-29	2001-01-31	0.08	0.16 %	Annual
1999-12-31	2000-01-31	0.13	0.19 %	Annual
1998-12-31	1999-01-29	0.03	0.06 %	Annual
1997-12-31	1998-01-30	0.11	0.29 %	Annual
		0.03	0.08 %	Annual
1995-12-29	1996-01-31	0.02	0.04 %	Annual
		0.02	0.05 %	Annual
		0.02	0.06 %	Annual
		0.01	0.02 %	Annual
		0.01	0.03 %	Annual

Recent News

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.

2025-05-19 13:01:00

Stryker declares an $0.84 per share quarterly dividend

Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better.

2025-05-08 08:00:00

Stryker reports first quarter 2025 operating results

Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billion Organic net sales increased 10.1% Reported operating income margin of 14.3% Adjusted operating income margin (1) increased 100 bps to 22.9% Reported EPS decreased 17.6% to $1.69 Adjusted EPS (1) increased 13.6% to $2.84 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 13.4 % (0.8) % 14.2 % 3.5 % 10.7 % Orthopaedics 9.7 (1.0) 10.7 1.4 9.3 Total 11.9 % (0.9) % 12.8 % 2.7 % 10.1 % “Our 2024 momentum continued into the first quarter as we delivered double-digit organic sales growth and continued to expand adjusted operating margins,” said Kevin A. Lobo, Chair and CEO.

2025-05-01 16:05:00

Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

Portage, Michigan, April 29, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2025 Global Healthcare Conference on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Preston Wells, Vice President and Chief Financial Officer, and Jason Beach, Vice President, Finance and Investor Relations.

2025-04-29 08:00:00

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the name VB Spine, LLC (“VB Spine”).

2025-04-01 16:26:00

Stryker completes sale of U.S. spinal implants business

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC.

2025-04-01 16:05:00

Stryker announces intention to nominate Manny Maceda to board of directors

Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company's board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.

2025-03-26 10:15:00

Stryker announces Annual Meeting of Shareholders

Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:

2025-03-25 16:15:00

Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego.

2025-03-11 08:03:00

Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

PORTAGE, Mich. , March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.

2025-03-06 13:36:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions